| Features: |
| CUSP9 coordinated undermining of survival paths with nine repurposed drugs -includes aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, sertraline, ritonavir |
| - | Analysis, | GBM, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:296 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid